| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70710-1203-1 | 70710-1203 | HUMAN PRESCRIPTION DRUG | Trientine hydrochloride | Trientine hydrochloride | CAPSULE | ORAL | 20190429 | N/A | ANDA | ANDA211554 | Zydus Pharmaceuticals USA Inc. | TRIENTINE HYDROCHLORIDE | 250 mg/1 | 1 BOTTLE in 1 CARTON (70710-1203-1) / 100 CAPSULE in 1 BOTTLE |
| 70771-1438-1 | 70771-1438 | HUMAN PRESCRIPTION DRUG | Trientine hydrochloride | Trientine hydrochloride | CAPSULE | ORAL | 20190429 | N/A | ANDA | ANDA211554 | Zydus Lifesciences Limited | TRIENTINE HYDROCHLORIDE | 250 mg/1 | 1 BOTTLE in 1 CARTON (70771-1438-1) / 100 CAPSULE in 1 BOTTLE |